Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (60)

2026

  1. Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)

    ESC heart failure, Vol. 13, Núm. 2

  2. Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysis

    HIV Medicine, Vol. 27, Núm. 1, pp. 96-105

  3. Bictegravir/emtricitabine/tenofovir alafenamide: A review of the real-world experience in Spain within the last five years

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 44, Núm. 2

  4. Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 1, pp. 58-73

  5. Comparable Inflammatory and Metabolic Outcomes after Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study)

    Clinical Infectious Diseases, Vol. 82, Núm. 2, pp. e262-e274

  6. Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 6

  7. Consensus Document on the Clinical Management of Frontal Fibrosing Alopecia: Recommendations From Spanish Working Group on Trichology and Onychology of the AEDV

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 1

  8. Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort

    AIDS, Vol. Publish Ahead of Print

  9. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  10. Effectiveness of a Comprehensive Program Including a Novel Concentrated High-Protein, High-Calorie Oral Nutritional Supplement to Enhance Nutritional and Morphofunctional Recovery in Malnourished Patients with Cancer: The ONAVIDA Study

    Nutrients , Vol. 18, Núm. 9

  11. Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort

    AIDS (London, England), Vol. 40, Núm. 4, pp. 414-427

  12. Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly

    Endocrine Practice, Vol. 32, Núm. 2, pp. 236-245

  13. Incidence and Clinical Characteristics of Hemorrhagic Manifestations in Children With Influenza: A Multicenter Retrospective Study

    Pediatric Infectious Disease Journal

  14. Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patients

    Seminars in Arthritis and Rheumatism, Vol. 78

  15. Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 5, pp. 690-709

  16. Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU

    Revista Espanola de Cardiologia, Vol. 79, Núm. 1, pp. 68-79

  17. Recurrence factors in familial papillary thyroid carcinoma

    Minerva endocrinology, Vol. 51, Núm. 1, pp. 4-16

  18. Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 1

  19. Safety of sonidegib in elderly patients with locally advanced basal cell carcinoma: A multicentre study

    Journal of the European Academy of Dermatology and Venereology

  20. Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)

    Clinical Infectious Diseases, Vol. 82, Núm. 3, pp. e511-e520